ChiCTR-TRC-10000982: Novaferon for chronic hepatitis B: a phase Ⅰrandomized open-label control trial |
|
|
| Completed | 4 | 40 | | Novaferon, 10ug intramuscular injection, once daily in the first day; Day 2 to day 7 not given the medication; followed injection 10ug a day, during week 2 to week 7 ;Novaferon, 10ug intramuscular injection, thrice weekly for week 1-6 ;Novaferon, 10ug intramuscular injection, once daily for the first week; followed by 20ug, thrice weekly for week 2-6 | Beijing YouAn Hospital, Capital Medical University; Genova Biotech Company, Ltd, Genova Biotech Company, Ltd. , National Novel Drug Development plan | Chronic Hepatitis B | | | | |
ChiCTR2100041835: Antiviral Therapy and Long-term Outcome of Chronic Hepatitis B Patients in China (CATLOB study): a National Multicenter, Prospective, Observational Real-World Study (Shan Dong Province) |
|
|
| Recruiting | 4 | 100 | | Treatment with Novaferon | Huashan Hospital of Fudan University; Qingdao Municipal Hospital, Self-paying from patients | chronic hepatitis B | | | | |
